Earnings Feed
Start Free
QuidelOrtho Corp·4

Feb 3, 7:51 PM ET

McLellan Philip D. 4

4 · QuidelOrtho Corp · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

QuidelOrtho (QDEL) COO Philip McLellan Receives Restricted Stock Units

What Happened

Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corporation (QDEL), received multiple restricted stock unit (RSU) awards: two large derivative grants of 36,152 and 36,150 RSUs (total 72,302) reported as acquired on Jan 30, 2026, plus smaller tranches (totaling 4,617 shares) that were converted/exercised around Jan 31, 2026. No cash was paid for the awards (grant price $0). To satisfy tax withholding obligations, the company withheld/disposed 2,333 shares on Jan 31, 2026 at $27.17 per share, generating cash proceeds applied to taxes of approximately $44,207.

Key Details

  • Transaction types: A = Award/Grant; M = Exercise/conversion of derivative; F = Payment for tax withholding (share disposition).
  • Dates: grants reported 2026-01-30; exercises/conversions and withholding occurred 2026-01-31.
  • Withheld shares: 2,333 shares withheld at $27.17/share for taxes, total ~$44,207 (dispositions coded F).
  • Awarded shares: two large derivative RSU grants of 36,152 and 36,150 shares (total 72,302 RSUs) reported as acquired at $0.00 (derivative); additional smaller tranches totaling 4,617 shares were converted/exercised.
  • Vesting: one 36,152 grant has 12,050 shares vesting Jan 30, 2027 and the remaining 24,102 vesting equally Jan 30, 2028 & Jan 30, 2029; the 36,150 grant vests in equal installments on Jan 30, 2027, 2028 and 2029. Other small tranches had prior vesting in 2025–2026 per footnotes.
  • Shares owned after the reported transactions: not specified in the filing.
  • Filing timeliness: Form 4 was filed Feb 3, 2026 for transactions dated Jan 30–31, 2026 (the filing indicates it was not filed within the usual two-business-day window).

Context

  • These were RSU awards converting to common stock; the tax-related dispositions were a share-withholding arrangement (routine), not open-market sales. Derivative entries (M) reflect conversion/exercise of RSUs into shares; F entries reflect shares retained/sold to satisfy tax withholding.
  • Such withholding transactions are common when restricted awards vest and do not necessarily indicate insider sentiment about the company’s stock.

Insider Transaction Report

Form 4
Period: 2026-01-30
QuidelOrtho CorpQDEL
McLellan Philip D.
Chief Operations Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-31+1,127→ 17,311 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-31$27.17/sh−421$11,439→ 16,890 total
  • Award

    Common Stock

    [F1]
    2026-01-31+847→ 17,737 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-31$27.17/sh−304$8,260→ 17,433 total
  • Award

    Common Stock

    [F1]
    2026-01-31+2,009→ 19,442 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-31$27.17/sh−674$18,313→ 18,768 total
  • Award

    Common Stock

    [F1]
    2026-01-31+634→ 19,402 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-31$27.17/sh−228$6,195→ 19,174 total
  • Award

    Restricted Stock Units

    [F3][F4]
    2026-01-30+36,152→ 36,152 total
    → Common Stock (36,152 underlying)
  • Award

    Non-Qualified Stock Options

    [F5]
    2026-01-30+36,150→ 36,150 total
    Exercise: $27.17Exp: 2036-01-30→ Common Stock (36,150 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F6]
    2026-01-31−1,127→ 0 total
    → Common Stock (1,127 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F7]
    2026-01-31−847→ 0 total
    → Common Stock (847 underlying)
  • Exercise/Conversion

    Restricted Stock Units (Converted)

    [F3][F8]
    2026-01-31−2,009→ 0 total
    → Common Stock (2,009 underlying)
  • Exercise/Conversion

    Restricted Stock Units (Premium )

    [F3][F8]
    2026-01-31−634→ 0 total
    → Common Stock (634 underlying)
Footnotes (8)
  • [F1]Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4.
  • [F2]Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
  • [F3]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • [F4]12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.
  • [F5]36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.
  • [F6]2,254 shares vested in equal installments on January 31, 2025 and January 31, 2026.
  • [F7]846 shares vested on January 31, 2025 and 847 shares vested on January 31, 2026.
  • [F8]Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule.
Signature
/s/ Jennifer Ahn, attorney-in-fact for Philip D. McLellan|2026-02-03

Documents

1 file
  • 4
    wk-form4_1770166259.xmlPrimary

    FORM 4